WeightWatchers buys health platform Sequence, facilitating access to Ozempic and Wegovy

WeightWatchers' acquisition of the digital health company Sequence represents a major step into the worlds of telehealth and medication-based obesity treatment.
WeightWatchers' acquisition of the digital health company Sequence represents a major step into the worlds of telehealth and medication-based obesity treatment.
This is additional taxonomy that helps us with analytics

Ozempic, Wegovy and other weight loss drugs present holiday challenges

Equip on LinkedIn: WeightWatchers buys telehealth platform Sequence, facilitating access to…

WeightWatchers buys health platform Sequence, facilitating access to Ozempic and Wegovy

WeightWatchers launches program for users of Ozempic and other weight-loss drugs - CBS News

Oprah Winfrey Discusses Weight Loss, Obesity and Ozempic

WeightWatchers rolls out telehealth clinic with GLP-1s

WeightWatchers seeks weight-loss drugs business in Sequence deal

With Ozempic popularity on the rise, WW jumps into obesity drugs market - Good Morning America

Ozempic, Wegovy and other weight loss drugs present holiday challenges

Wegovy (semaglutide) to be available in UK pharmacies

Oprah's Weight Loss Dilemma: The Ozempic

Weight Watchers buys Sequence, will offer weightloss drugs like Wegovy

Ozempic, Wegovy force weight loss companies to upend their approaches